The C1B domains of novel PKCε and PKCη have a higher membrane binding affinity than those of the also novel PKCδ and PKCθ  by Egea-Jiménez, Antonio L. et al.
Biochimica et Biophysica Acta 1838 (2014) 1898–1909
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemThe C1B domains of novel PKCε and PKCη have a higher membrane
binding afﬁnity than those of the also novel PKCδ and PKCθAntonio L. Egea-Jiménez, Senena Corbalán-García, Juan C. Gómez-Fernández ⁎
Departamento de Bioquímica y BiologíaMolecular “A”, Facultad de Veterinaria, Regional Campus of International Excellence “CampusMare Nostrum”, Universidad deMurcia, Apartado de Correos
4021, E-30080 Murcia, SpainAbbreviations: OG-PE, N-(5-dimethylaminonaphthalene
sn-glycero-3-phosphoethanolamine; DOG, 1,2-sn-dioleoylgly
rescent protein; SAG, 1-stearoyl-oleoyl-sn-glycerol; DPG, 1,2
1,2-dioctanoyl-sn-phosphatidic acid; POPG, 1-palmitoyl-2-
POPA, 1-palmitoyl-2-oleoyl-sn-phosphatidic acid; POPC, 1-pa
choline; POPS, 1-palmitoyl-2-oleoyl-sn-phoshatidylserine;DO
parent equilibrium dissociation constant
⁎ Corresponding author. Tel.: +34 868884766.
E-mail address: jcgomez@um.es (J.C. Gómez-Fernánde
http://dx.doi.org/10.1016/j.bbamem.2014.04.003
0005-2736/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 27 January 2014
Received in revised form 28 March 2014
Accepted 2 April 2014
Available online 13 April 2014
Keywords:
PKC
C1 domain
Diacylglycerol
Membrane binding
Protein–lipid interactionThe C1 domains of novel PKCs mediate the diacylglycerol-dependent translocation of these enzymes. The four
different C1Bdomains of novel PKCs (δ, ε, θ andη)were studied, togetherwith different lipidmixtures containing
acidic phospholipids and diacylglycerol or phorbol ester. The results show that either in the presence or in the
absence of diacylglycerol, C1Bε and C1Bη exhibit a substantially higher propensity to bind to vesicles containing
negatively charged phospholipids than C1Bδ and C1Bθ. The observed differences between the C1B domains of
novel PKCs (in two groups of two each) were also evident in RBL-2H3 cells and it was found that, as with
model membranes, in which C1Bε and C1Bη could be translocated to membranes by the addition of a soluble
phosphatidic acid without diacylglycerol or phorbol ester, C1Bδ and C1Bθ were not translocated when soluble
phosphatidic acidwas added, and diacylglycerol was required to achieve a detectable binding to cellmembranes.
It is concluded that two different subfamilies of novel PKCs can be established with respect to their propensity to
bind to the cell membrane and that these peculiarities in recognizing lipids may explain why these isoenzymes
are specialized in responding to different triggering signals and bind to different cell membranes.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
PKC (protein kinase C) is a large family of phospholipid-dependent
serine/threonine kinases, which are activated by many extracellular
signals, and which play a critical role in several signaling pathways in
the cell. Mammalian isoenzymes have been grouped into three subfam-
ilies according to their enzymatic properties. The ﬁrst group, called
classical or conventional isoenzymes (cPKCs), includes PKCα, βI, βII
and γ, all of which contain the conserved C1 and C2 domains in the
regulatory region. These isoenzymes are regulated by Ca2+ and acidic
phospholipids, which interact with the C2 domain, and by DAG (diacyl-
glycerol), which interacts with the C1 domain [1,2]. Classical PKC
isoenzymes are translocated to the plasma membrane of mammalian
cells when the Ca2+ concentration is increased in the cytoplasm
through the bridging made by this cation between the C2 domain and
negatively charged phospholipids in the membrane (with preference-1-sulfonyl)-1,2-dihexadecanoyl-
cerol; ECFP, enhanced cyan ﬂuo-
-sn-dipalmitoylglycerol; DOcPA,
oleoyl-sn phosphatidylglycerol;
lmitoyl-2-oleoyl-sn-phosphatidyl-
cG, 1,2-dioctanoylglycerol;KD, ap-
z).phosphatidylserine) [3], and also by interaction with PIP2 in the
membrane through a second site [4–7], followed by C1 domain–diacyl-
glycerol interactions [2,8,9]. In contrast, the enzymes of the novel PKC
subfamily (δ, ε, θ and η) do not bind Ca2+ and are activated through
diacylglycerol or phorbol esters binding to the C1 domain [1], although
the C2 domain also plays a role through interactions with ligands like
phosphatidic acid [10,11].
Both classical and novel PKCs possess two different C1 domains,
which form a tandem in the regulatory domain, C1A and C1B. A large
number of experimental observations suggest that both domains are
functionally dissimilar, as is evident for example, from their different
afﬁnities for diacylglycerols or phorbol esters [2,12–15]. The afﬁnity of
C1A and C1B for these ligands changes depending on the isoenzyme in
question. For example, it has been described that whereas the C1A
domain of PKCα shows a much higher DAG afﬁnity than the C1B
domain, furthermore, the C1A has also a higher afﬁnity for phorbol
esters than the C1B but afﬁnities are not so different in this case [13,
16]. In the case of other classical isoenzymes, like β [13] and γ [12,13,
16,17] differences are not big for diacylglycerol or phorbol ester afﬁni-
ties between the C1A and C1B domain afﬁnities.
For PKCδ, conﬂicting results have been published, one group [13]
claiming that C1B has a much higher binding afﬁnity for diacylglycerol
than C1A, while another group [18] maintains that the opposite is
true. PKCε is similar to PKCγ in that both C1A and C1B domains are
involved in membrane binding and activation, although the C1A domain
has about a 3-fold higher DAG afﬁnity than the C1B domain [19]. With
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but it seems that in both θ andη the C1Bdomain has a higher afﬁnity than
the C1A domain for phorbol esters [13,17].
It has long been known that phosphatidylserine enhances the
membrane afﬁnity and activity of PKCs [20], although it has also been
claimed that the phosphatidylserine dependence may vary signiﬁcantly
among PKC isoforms [16,21]. Among conventional PKCs, PKCα [21] and
PKCβII [22] prefer PS to phosphatidylglycerol, whereas PKCγ shows little
preference between phosphatidylserine and phosphatidylglycerol [16].
Among novel PKCs, PKCδ shows a certain degree of phosphatidylserine
selectivity [18], whereas PKCε does not [19,21].
Nevertheless, it should be taken into account that both the C1 and C2
domains bind anionic phospholipids, and so it is difﬁcult to use whole-
enzyme activity to detect from which domain the observed speciﬁcity
arises. For this reason, it is important to study the isolated domains. In
the case of the C1 domain, only a limited number of studies have been
carriedout for this purpose, and, among theﬁndings, itmaybementioned
that the C1B domain of PKCβII (in the presence of diacylglycerol) has a
dissociation constant of 780 μM in the presence of phosphatidylserine
and 1690 μM in the presence of phosphatidylglycerol [23]. However,
when a Tyr residue wasmutated to Trp, the C1B domain showed a disso-
ciation constant of 24 μM for a membrane containing phosphatidylserine
and 130 μM for a membrane containing phosphatidylglycerol, i.e.,
although the constant was considerably reduced, the preference was
not a pronounced preference for phosphatidylserine [24]. In the case of
C1Bδ, it was clearly shown that the preferencewas for phosphatidylserine
(KD of 35 μM) rather than for phosphatidylglycerol (KD of 700 μM) [23].
A studywas carried out using isolated C1Bdomains of three different
PKCs (the classical γ, and the novel δ and ε) binding to liposomes of dif-
ferent compositions, using three different DAGs (DOG, SAG and DPG)
and three different anionic phospholipids (phosphatidylserine, phos-
phatidic acid and phosphatidylglycerol) to prepare the model vesicles.
C1Bε was found to have the highest binding afﬁnity to vesicles
containing phosphatidic acid as acidic phospholipid, and DOG or
SAG as diacylglycerol. In general, DOG and SAG led to a higher mem-
brane binding afﬁnity than DPG in all the C1B domains [25]. In this
paper we amplify this study by comparing, side by side, the four
C1B domains from novel PKCs, and their afﬁnities for membranes
containing different negatively charged phospholipids. Two groups
could be established, one with a lower KD for model membranes,
constituted by C1Bε and C1Bη, and another formed by C1Bδ and
C1Bθ which show substantially higher KD. The lowest KD in the case
of C1Bε and C1Bη was observed for membranes containing POPA.
These differences in membrane afﬁnities were conﬁrmed by
expressing the four domains in RBL-2H3 cells and triggering the translo-
cation to the plasma membrane by adding a soluble phosphatidic acid or
a soluble diacylglycerol.
2. Materials and methods
2.1. Materials
All lipids were obtained from Avanti Polar Lipids (Alabaster, Alabama,
USA). Oregon Green 488-dihexadecanoylphosphatidylethanolamine
(OG-PE) was obtained from Invitrogen, Barcelona, Spain. Phorbol-12-
myristate-13-acetate (PMA) was purchased from Sigma Chemical Co.
(Madrid, Spain).
2.2. Construction of the expression plasmids
C-terminal fusions of isolatedC1domainswere generated by inserting
cDNAs into the multiple cloning site of the pECFP vector modiﬁed and
described by [25].
Brieﬂy, cDNAs encoding C1B domains of PKCθ, δ and εwere ampliﬁed
by PCR using the following primers:C1Bθ: 5′ CGGAATTCATCGCTTTAAAGTGTAT
C1Bθ: 3′ CCCAAGCTTTCAGCACAGGTTCGCCAC
C1Bδ: 5′ TATAAGCTTGACATGCCTCACCGA
C1Bδ: 3′ GACACACCATAGTTGACTCCTAGGAA
C1Bε: 5′ CCGAAGCTTAACATGCCCCACAAG
C1Bε: 3′ GTTAACACCCCACCTGACTGGGCCCTAAA
C1Bεwas digestedwithHindIII/XmaI, C1BδwasdigestedwithHindIII/
BamHI and C1Bθwas digested with EcoRI/ BamHI. C1Bηwas synthesized
and cloned into the EcoRI andBamHI sites of the plasmid vector pUC57by
GenScript Corporation (Piscataway, New Jersey, USA). The resulting
fragments were ligated with their corresponding digested vectors to
generate the different fusion constructs.
All constructs were conﬁrmed by DNA sequencing in the Research
and Development Support Center (CAID), Universidad de Murcia
(Spain).
2.3. Cell culture and transfections
HEK 293 cells (ECACC, European Collection of Cell Cultures) were
cultured in DMEM supplemented with 10% fetal bovine serum. Cells
were transfected with 2 μg DNA/6 cm plate using Lipofectamine-2000
(Invitrogen, Carlsbad, CA) following the instructions provided by the
manufacturer. The cells were lysed 24 h after transfection in ice-cold
hypotonic buffer (10 mM Tris pH 7.4, 10 mM NaF, 1 mM orthovanadate,
1 mM PMSF and 10 μg/ml each aprotinin and leupeptin) and incubated
on ice (20 min). Cells were lysed by 15 passages through a 30-gauge
needle; lysates were centrifuged (15,000 ×g, 15 min) to remove nuclei
and cell debris. Supernatants were collected and used in the ﬂuorescence
experiments.
Rat basophilic leukemia (RBL-2H3) cells were cultured at 37 °C in a
humidiﬁed atmosphere of 5% CO2 in a growth medium of Dulbecco's
modiﬁed Eagle's Medium supplemented with 15% (vol/vol) fetal calf
serum. Cells were prepared for confocal microscopy as described by
[10]. Basically, harvested cellswere resuspended in electroporation buffer
(120 mM NaCl, 5.5 mM KCl, 2.8 mM MgCl2, 25 mM glucose, 20 mM
HEPES, pH 7.2) and 30 μg of cDNA. The cells were electroporated in a
GenePulser (Bio-Rad, Hercules, CA) with one 200 V/10 ms square wave
pulse and immediately placed on ice for 5 min before being plated on
glass coverslips and incubated at 37 °C for 4–6 h, after which the growth
medium was renewed. RBL cells were used 16–24 h later after priming
overnight with 500 ng/ml IgE-anti-dinitrophenyl (mouse monoclonal;
Sigma-Aldrich Quimica, S.A., Madrid, Spain) and stimulation was per-
formed using 2 μg/ml dinitrophenyl-human serum albumin [DNP-HSA].
The coverslips were washed with 3 ml of extracellular buffer HBS
(120 mM NaCl, 25 mM glucose, 5.5 mM KCl, 1.8 mM CaCl2, 1 mM
MgCl2, 20 mM HEPES pH 7.2). All added substances were dissolved or
diluted inHBS. 1,2-Dioctanoylglycerol (DOcG) andDOcPAwere dissolved
in dimethyl sulfoxide and diluted to theﬁnal concentrationwith extracel-
lular buffer shortly before the experiment. During the experiment, the
cells were not exposed to dimethyl sulfoxide concentrations higher
than 1%. All the experiments were carried out at room temperature and,
unless otherwise stated, on at least four different occasions. In eachexper-
iment, recordings were obtained from two to six cells.
2.4. Binding of C1B-ECFP domains to lipid vesicles
Binding experimentswere carried out using small unilamellar vesicles
obtained by sonication ofmultilamellar vesicles, whichwere prepared by
desiccating mixtures of chloroform solutions of lipids in the suitable
proportions and extensive vortexing. Lipid mixtures contained phospho-
lipids POPC/POPX/OG-PE, in the desired proportions, where POPX stands
for POPS, POPA or POPG and diacylglycerols (DOG) or phorbol esters
(PMA). Binding experiments were performed at 25 °C, using a
FluroMax-3 (Jobin Yvon, Horiba, Edison, NJ, USA), with a 20 mM Hepes
(pH 7.4) and 100 mM KCl buffer. The excitation and emission windows
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between different experiments, cell lysates were added to the ﬂuores-
cence cuvette to reach the same starting ECFP ﬂuorescence intensity.
FRET was measured as the ﬂuorescence variation of ECFP as a function
of lipid concentration. The intensity of ECFP ﬂuorescence was measured
using an excitation wavelength of 433 nm and collected at 473 nm. To
correct for the ﬂuorescence attenuation produced by the lipidic vesicles,
a control was measured in which vesicles containing only POPC and
OG-PEwere added to a cuvettewith C1B-ECFP, while the values obtained
were subtracted from these of the above experiments. Additionally, the
dilution effect produced by the addition of vesicles was corrected by
subtracting the values obtained after adding the same volumes of buffer
without lipid vesicles to a cuvette containing the C1B domain. The
mean values of three different experiments are shown.
Equilibrium binding data were best-ﬁtted using the Hill Eq. (1):
ΔF ¼ ΔFmax XH=KDH þ XH
 
ð1Þ
where ΔFmax represents the calculated maximal ﬂuorescence change
(normalized to unity to simplify graphical representation), H is the
Hill coefﬁcient, X represents the free phospholipid concentration
corrected for the leaﬂet effect (for phospholipid titrations) and KD
represents the apparent equilibrium dissociation constant for lipid
binding and corresponds to the inverse of the afﬁnity constant. Note
that the amount of protein added is very low since it is comes from
the cell lysates of C1B-overexpressing HEK293 cells, and from the ﬁrst
lipid additions when the [protein]≪ [lipid]. Therefore, free concentra-
tions of phospholipid can be assumed to be approximately the same as
the total lipid concentrations.
2.5. Confocal microscopy
Cells expressing various C1B-ECFP constructs were washed with
HBS and examined using a TCS SP confocal system (Leica, Heidelberg,
Germany) with a Nikon PLAN APO-CS 63 × 1.2 numerical aperture
water immersion objective.
Confocal images were obtained by excitation at 405 nm and emission
wavelengths at 470–475 nm for CFP. During imaging, cellswere stimulat-
ed with DNP-HSA, DOcG or DOcPA. Series of 60–120 confocal images
were recorded for each experiment at time intervals of 3 s.
2.6. Image analysis
Background was subtracted from the images before the calculations
were performed. The time series were analyzed using Image J NIH
software (http://rsb.info.nih.gov/ij/, 1997–2003). An individual analysis
of protein translocation for each cell was performed by tracing a line
intensity proﬁle across the cell [26]. The relative increase in the amount
of enzyme localized in the plasma membrane for each time point was
calculated by using the ratio R (Imb Icyt)/Icyt, where Imb is the ﬂuores-
cence intensity at the plasmamembrane and Icyt is the average cytosolic
ﬂuorescence intensity. Mean values are given SE of the mean.
3. Results
The aim of this work was to study the membrane binding afﬁnity of
C1 domains of novel PKCs for different anionic phospholipids in the
presence or absence of DOG or PMA. C1B domains from PKCδ, PKCε,
PKCη and PKCθ were used.
Since these C1B domains lack suitable residues to induce ﬂuorescence
energy transfer between a membrane probe and Trp residues, a FRET
method was used, in which the acceptor was phosphatidylethanolamine
labeled with Oregon Green-488 (OG-PE) located in the membrane, and
the donorwas the C1 domain fused to enhanced cyan ﬂuorescent protein(ECFP). In a second phase the membrane translocation of these C1B
domains fused to a ﬂuorescent protein was examined in RBL-2H3.3.1. The inﬂuence of acidic phospholipids on the binding of C1B domains to
membrane in the presence of DOG
Using the FRETmethodmentioned above, the binding of C1B domains
to small unilamellar vesicles containing different lipid compositions was
studied. Fig. 1 shows the binding of the C1Bδ domain to increasing
concentrations of POPC/POPX/DOG vesicles, where POPX stands for
POPS (Fig. 1A), POPG (Fig. 1B) or POPA (Fig. 1C). In this assay, the effect
of increasing the relative percentage of acidic phospholipid on C1Bmem-
brane bindingwas also studied. The datawere analyzed and best-ﬁtted to
theHillmodel. The diacylglycerol (DOG) concentrationwas kept constant
at 5 mol% in all the following cases.
C1Bδ (Fig. 1, Table 1) showed the highest binding afﬁnity for mem-
branes when POPS was present although all the values were within the
same order of magnitude (at 40 mol% of anionic phospholipids, the KD
was 11.57 ± 0.2 μM for POPS compared to 19.55 ± 0.4 μM for POPA
and 37.54 ± 0.7 μM for POPG).
In the case of C1Bθ (Fig. 1, Table 1), the lowest KD corresponded to
membranes incorporating POPA (Fig. 1F), followed by those with
POPS (Fig. 1D) and ﬁnally those with POPG (Fig. 1E), although all of
them were in the same order of magnitude (at 40 mol% of the anionic
phospholipids, the KD was 6.78 ± 1.19 μM for POPA, 11.99 ± 1.79 for
POPS and 22.64 ± 1.01 μM for POPG).
When the binding of C1Bε was studied, it was observed (Fig. 2 and
Table 1) that the extent of binding was much higher than with the
two previously mentioned isoenzymes. In this case, the highest bind-
ing afﬁnitywas very clearly for POPA (Fig. 2C), followed by POPS (Fig,
2A) and POPG (Fig. 2B and Table 1) (at 40 mol% of the anionic phos-
pholipids, the KD was 0.27 ± 0.05 μM for POPA, 1.01 ± 0.19 μM for
POPS and 3.01 ± 0.45 μM for POPG).
In the case of C1Bη, binding afﬁnities weremore similar to those ob-
served for the ε isoenzyme than to those observed for the δ and θ isoen-
zymes. As with the PKC-C1Bε, the highest binding afﬁnity was observed
for POPA (Fig. 2F), followed by POPS (Fig. 2D) and POPG (Fig. 2E) (at
40 mol% of the anionic phospholipids, the KD was 0.40 ± 0.08 μM for
POPA, 0.98 ± 0.81 for POPS and 1.08 ± 0.15 μM for POPG) (Table 1).
An interesting ﬁndingwas the important role played by anionic phos-
pholipids in the binding of C1B domains to the membranes (Table 1). As
the contents of the anionic phospholipids increased from 5 to 40 mol%,
the membrane binding afﬁnity increased up to one order of magnitude
at a constant DOG concentration (5 mol%). See, for example, the case of
C1Bεwith POPA, with KD 2.74 ± 0.48 μM at 5 mol% and 0.27 ± 0.05 μM
at 40 mol%; or that of C1Bηwith POPA, when the increase was from KD
of 3.63 ± 1.15 μM at 5 mol% and 0.40 ± 0.08 μM at 40 mol% (Table 1).
These results conﬁrm that not only is diacylglycerol important for the
binding of C1 domains to the membrane, but that anionic phospholipids
are also important.
Another interesting result was that there were substantial differences
in the binding afﬁnity of the domains studied. The highest binding afﬁn-
ities were observed in C1Bε (Fig. 2 and Table 1) for the three anionic
phospholipids, the increase being about 25-fold for 40 mol% of POPA
(KD values of 0.27 ± 0.05 μM for C1Bε compared with 19.55 ± 0.4 μM
for C1Bδ and 6.78± 1.19 μM for C1Bθ). More similarwere themembrane
binding afﬁnities of isoenzyme δ comparedwith θ and that of ε compared
with η. Increases of up to 10-fold were also observed in the presence of
40 mol% POPS (KD values of 1.01 ± 0.19 μM for C1Bε compared to
11.99 ± 1.79 μM for C1Bθ and 11.57 ± 0.2 μM for C1Bδ) and up to
37-fold when 40 mol% POPG was present in the membrane (KD values
of 1.08 ± 0.15 μM for C1Bη and 3.01 ± 0.45 for C1Bε compared with
22.64 ± 1.01 μM for C1Bθ and 37.54 ± 0.7 μM for C1Bδ).
Thus, in general, similarmembrane binding afﬁnities were observed
for C1Bθ and C1Bδ and, on the other hand, for C1Bε and C1Bη.
Fig. 1. Binding of C1Bδ and C1Bθ to lipid vesicles in the presence of DOG. Binding of C1Bδ-ECFP domain (A, B and C) and C1Bθ-ECFP domain (D, E and F) to lipid vesicles, which contained
different types of anionic phospholipids. Vesicles contained POPC/POPX/OG-PE inmolar ratios of 90:5:5 (•), 85:10:5 (o), 75:20:5 (▼), and 55:40:5 (∇). POPXwas POPS (A and D), POPG (B
and E) or POPA (C and F). DOG was present in all cases at 5 mol%. Normalized FRET values are depicted versus total lipid concentration.
Table 1
Binding parameters of C1B-ECFP domains to phospholipid vesicles.
C1Bδ C1Bθ C1Bε C1Bη
mol% ΔFmax (%) KD (μM) ΔFmax (%) KD (μM) ΔFmax × (%) KD (μM) ΔFmax (%) KD (μM)
POPS 5 0.12 ± 0.02 40.15 ± 0.4 0.32 ± 0.02 40.25 ± 0.78 0.46 ± 0.01 6.76 ± 0.66 0.45 ± 0.01 6.28 ± 0.63
10 0.20 ± 0.01 28.22 ± 0.2 0.35 ± 0.01 39.36 ± 0.53 0.46 ± 0.02 3.23 ± 0.62 0.59 ± 0.03 2.55 ± 0.15
20 0.24 ± 0.02 22.60 ± 0.2 0.38 ± 0.02 20.92 ± 0.49 0.60 ± 0.01 1.91 ± 0.12 0.58 ± 0.02 2.02 ± 0.04
40 0.30 ± 0.01 11.57 ± 0.2 0.42 ± 0.01 11.99 ± 1.79 0.61 ± 0.03 1.01 ± 0.19 0.61 ± 0.03 0.98 ± 0.81
POPA 5 0.11 ± 0.03 35.33 ± 0.4 0.44 ± 0.01 30.39 ± 1.46 0.54 ± 0.01 2.74 ± 0.48 0.45 ± 0.01 3.63 ± 1.15
10 0.16 ± 0.02 30.29 ± 0.4 0.44 ± 0.01 26.02 ± 0.93 0.57 ± 0.01 1.69 ± 0.06 0.47 ± 0.01 1.89 ± 0.21
20 0.21 ± 0.05 20.40 ± 0.8 0.46 ± 0.01 9.66 ± 1.13 0.62 ± 0.01 1.18 ± 0.08 0.43 ± 0.01 1.11 ± 0.03
40 0.30 ± 0.01 19.55 ± 0.4 0.52 ± 0.01 6.78 ± 1.19 0.65 ± 0.01 0.27 ± 0.05 0.52 ± 0.01 0.40 ± 0.08
POPG 5 0.43 ± 0.01 64.78 ± 0.2 0.26 ± 0.01 42.49 ± 2.89 0.50 ± 0.01 8.03 ± 0.55 0.42 ± 0.01 12.6 ± 0.64
10 0.43 ± 0.02 52.67 ± 0.2 0.30 ± 0.01 37.74 ± 2.61 0.61 ± 0.01 6.32 ± 0.42 0.44 ± 0.01 5.01 ± 0.54
20 0.52 ± 0.01 48.29 ± 0.2 0.29 ± 0.01 28.88 ± 2.56 0.64 ± 0.02 4.18 ± 0.45 0.44 ± 0.01 3.71 ± 0.65
40 0.53 ± 0.01 37.54 ± 0.7 0.37 ± 0.01 22.64 ± 1.01 0.67 ± 0.01 3.01 ± 0.45 0.53 ± 0.03 1.08 ± 0.15
Phospholipid vesicle contained POPC/DOG/POPX/OG-PE (X:5:X:5 mol%),whereas anionic and POPC phospholipids varied as indicated in the table. FRET data were ﬁtted to a Hill equation.
Values given as mean ± SE of three independent experiments in triplicates (n = 9).
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Fig. 2. Binding of C1Bε and C1Bη to lipid vesicles in the presence of DOG. Binding of C1Bε-ECFP domain (A, B and C) and C1Bη-ECFP domain (D, E and F) to lipid vesicles, which contained
different types of anionic phospholipids. Vesicles contained POPC/POPX/OG-PE inmolar ratios of 90:5:5 (•), 85:10:5 (o), 75:20:5 (▼) and 55:40:5 (∇). POPXwas POPS (A and D), POPG (B
and E), or POPA (C and F). DOG was present in all cases at 5 mol%. Normalized FRET values are depicted versus total lipid concentration.
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membrane in the absence of diacylglycerol or in the presence of PMA
The binding dependency of the C1B domains to lipid vesicles was also
studied in the total absence of diacylglycerol. Fig. 3 shows a comparison of
the four C1B domains studied, in the presence of 20mol% of each anionic
phospholipid. The existence of two groups of C1B domains delimited by
their membrane binding afﬁnity is clearly revealed by these results,
especially in the presence POPA (Fig. 3C) and POPS (Fig. 3A). The same
pattern was found in the presence of POPG (Fig. 3B) although with a
less pronounced separation between the two pairs. Table 2 shows that
KD values had a similar order of magnitude for membranes containing
any of the anionic phospholipids tested in the case of C1Bδ and C1Bθ,
ranging from 32.06 ± 0.46 μM for C1Bδ with POPS to 52.21 ± 0.84 μM
for the same C1Bδ with POPG. These ﬁgures were much lower in the
case of C1Bε (KD values of 25.43 ± 0.19 μM for POPS, 3.02 ± 0.34 for
POPA and 21.61 ± 0.39 for POPG) and for C1Bη (KD values of 9.48 ±
0.80 μM for POPS, 1.82 ± 0.5 for POPA and 15.98 ± 0.76 for POPG).Note the strongly decreased value in the presence of POPA, indicating
that in these cases membrane translocation may already be quite high
even without diacylglycerol. The addition of 5 mol% DOG increases
membrane afﬁnity in all cases compared with membranes without any
diacylglycerol, but especially with C1Bε and C1Bη, revealing once again
the higher afﬁnity for membranes of these two domains. Such was the
case of C1Bε with POPS (KD 25.43 ± 0.19 in the absence and 1.91 ±
0.12 μM in the presence of DOG) and with POPG (KD 21.61 ± 0.39 in
the absence and 4.18 ± 0.45 μM in the presence of DOG) and also of
C1Bη with POPS (KD 9.48 ± 0.80 in the absence and 2.02 ± 0.04 μM in
the presence of DOG) and POPG (KD 15.98 ± 0.76 in the absence and
3.71 ± 0.65 μM in the presence of DOG). The decrease in KD values was
less marked in the presence of POPA in the case of C1Bε (from 1.18 ±
0.08 μM in the presence of DOG to 3.02 ± 0.34 in its absence) and for
C1Bη (1.11 ± 0.03 μM in the presence and 1.82 ± 0.5 in the absence of
DOG).
In the presence of 1 mol% of PMAwith respect to the total lipid, how-
ever (Fig. 4)membranebinding afﬁnitieswere similar for all C1Bdomains
Fig. 3. Binding of C1B domains to lipid vesicles in the absence of DOG. Binding of C1Bθ-
ECFP(o), C1Bε-ECFP(•), C1Bη-ECFP(∇) and C1Bδ-ECFP(▼) domains to lipid vesicles,
which contained POPC/POPX/OG-PE in molar ratio of 75:20:5. POPX was POPS (A),
POPG (B) or POPA (C). Normalized FRET values are depicted versus total lipid
concentration.
Fig. 4. Binding of C1B domains to lipid vesicles in the presence of PMA. Binding of C1Bθ-
ECFP (o), C1Bε-ECFP (•), C1Bη-ECFP (∇), and C1Bδ-ECFP (▼) domains to lipid vesicles
contained POPC/POPX/PMA/OG-PE in molar ratio of 74:20:1:5. POPX was POPS (A),
POPG (B) or POPA (C). Normalized FRET values are depicted versus total lipid
concentration.
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was at saturating concentration and that all these domains are able to
translocate to the membrane if the concentration of activating molecules
is sufﬁciently high (see also Table 3). Note that the KD values reached in
this case for C1Bε and C1Bη were not much lower than those reachedTable 2
Binding parameters of C1B-ECFP domains to phospholipid vesicles.
mol% DOG C1Bδ C1Bθ C1Bε C1Bη
KD (μM) KD (μM) KD (μM) KD (μM)
POPS 0 32.06 ± 0.46 47.02 ± 0.68 25.43 ± 0.19 9.48 ± 0.80
5 22.60 ± 0.20 20.92 ± 0.49 1.91 ± 0.12 2.02 ± 0.04
POPA 0 43.65 ± 0.79 41.35 ± 0.88 3.02 ± 0.34 1.82 ± 0.50
5 20.40 ± 0.83 9.66 ± 1.13 1.18 ± 0.08 1.11 ± 0.03
POPG 0 52.21 ± 0.84 44.94 ± 0.65 21.61 ± 0.39 15.98 ± 0.76
5 48.29 ± 0.25 28.88 ± 2.56 4.18 ± 0.45 3.71 ± 0.65
Phospholipid vesicle contained 75 mol% POPC, X mol % of DOG, 5 mol% OG-PE, and
20 mol% of the indicated anionic phospholipid. FRET data were ﬁtted to a Hill equation.
Values given as mean ± SE of three independent experiments in triplicates (n = 9).with 5mol% DOG and even in the presence of POPA (in the total absence
of DOG or PMA), as it occurred for C1Bηwith POPA (KDwas 1.82± 0.5 in
the absence of DOG and PMA, but 1.11 ± 0.03 μM in the presence of
5 mol% DOG and 1.01 ± 0.12 in the presence of 1 mol% PMA). This indi-
cates that these C1B domains may reach nearly maximum membrane
binding in the presence of POPA alone.Table 3
Binding parameters of C1B-ECFP domains to phospholipid vesicles.
Mol (%) PMA C1Bδ C1Bθ C1Bε C1Bη
KD (μM) KD (μM) KD (μM) KD (μM)
POPS 1 0.74 ± 0.06 3.71 ± 0.17 1.39 ± 0.06 0.86 ± 0.44
POPA 1 1.32 ± 0.20 2.14 ± 0.12 0.49 ± 0.07 1.01 ± 0.12
POPG 1 1.46 ± 0.15 5.15 ± 0.12 2.67 ± 0.12 1.14 ± 0.19
Phospholipid vesicle contained 74 mol% POPC, 1 mol% of PMA, 5 mol% OG-PE, and
20 mol% of the indicated anionic phospholipid. FRET data were ﬁtted to a Hill equation.
Values given as mean ± SE of three independent experiments in triplicates (n = 9).
Table 4
Plasma membrane translocation parameters in RBL-2H3 cells stimulated with antigen
DNP-HSA.
Stimulation 2 μg/ml DNP-HSA N cells M.L., % Rmax t½, s
C1Bε-ECFP 62 80 0.62 ± 0.01 19 ± 2
C1Bη-ECFP 77 76 0.59 ± 0.02 23 ± 2
C1Bδ-ECFP 63 61 0.52 ± 0.03 37 ± 2
C1Bθ-ECFP 50 66 0.56 ± 0.02 40 ± 6
RBL2H3 cells were primed with 0.5 μg/ml antiIgE antibody for 16 h and then stimulated
with 2 μg/ml DNP-HSA. M.L. is membrane localization and indicates the percentage of
cells responding to DNP-HSA stimulation with plasma membrane translocation. Rmax is
the maximal relative increase in plasma membrane localization of the domain. t1/2 is the
half time of translocation.
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cell activation and endogenous production of activators
To investigate membrane translocation of the four domains in a
cellular contextwehave used RBL-2H3 cells transfectedwith the different
protein C1B-ECFP constructs. These cells may be activated by their stimu-
lation of the RBL-2H3 cells by an antigen asDNP-HSA. The cross-linking of
the high-afﬁnity IgE receptor (FcεRI) with antigen in mast or basophilic
cells (as the RBL-2H3 ones) stimulates a number of lipid-signaling events,
which include the activation of phospholipase Cγ phospho-inositide
3-kinase, and phospholipase D (PLD) [72–74] andmany serine/threonine
kinases [75–77], including the PKC family among others [78]. Diacylglyc-
erols are generated through this stimulation and also phosphatidic acid
(López-Andreo et al. 2003).
The results obtained (Table 4 and Fig. 5A) indicate that the four
domainsmay be translocated to the plasmamembrane after the stimula-
tion of the cells but some differenceswere observed between them.With
respect to Rmax C1Bε and C1Bη present slightly higher values (0.62 ±
0.01 and 0.59 ± 0.02, respectively) than C1Bδ and C1Bθ (0.52 ± 0.03
and 0.56 ± 0.02, respectively) but substantial differences were observed
for t½with values remarkably lower for C1Bε and C1Bη (19±2 and 23±
2 s, respectively) in comparison to C1Bδ and C1Bθ (37 ± 2 and 40 ± 6 s,
respectively). This means that higher concentrations of activating factors
are needed for the second couple of domains and thus a longer time for
the membrane translocation is needed, although they are able of doing
so, as it was also shown with the model system when PMA was added
(Table 3).3.4. Membrane translocation of C1B domains in RBL-2H3 cells induced by
permeable activators
To check the importance of phosphatidic acid and diacylglycerol on
the membrane translocation of the four domains and if the lag response
observed for C1Bδ and C1Bθ is really due to their need of higher concen-
trations of activators, water soluble forms of the lipids were used that are
known to permeate the membranes, namely phosphatidic acid (DOcPA)
and soluble diacylglycerol (DOcG).
Table 5 shows that when a high concentration (20 μg/ml) of DOcPA
was added to RBL-2H3 cellsmembrane translocationwas induced in the
case of C1Bε and C1Bη (Rmax 0.44± 0.22 and 0.41 ±0.02, respectively).
The addition of low concentrations of DOcPA (10 μg/ml) (Fig. 5B and
Table 5) led to still detectable membrane translocation (Rmax 0.33 ±
0.03 and 0.21 ± 0.02, respectively).
On the other hand, the addition of 12 μg/ml of DOcGwithout DOcPA
(Table 5) induced considerable membrane translocation (Rmax 0.46 ±
0.02 for C1Bε and 0.41± 0.01 for C1Bη). Considerable less translocation
was observed (Fig. 5C and Table 5) when only 4 μg/ml of DOcG was
added (Rmax 0.29±0.03 for C1Bε and 0.26±0.01 for C1Bη). An additiveFig. 5.Membrane translocation of C1B domains to the plasma membrane of RBL-2H3 cells. Cel
indicated. The pictures show the effect of the addition of antigen (DNP-HSA) or the indiceffect was observed when DOcPA (10 μg/ml) and DOcG (4 μg/ml) were
added together (Fig. 5D and Table 5) producing, in this case, a good level
of translocation (Rmax 0.51 ± 0.01 for C1Bε and 0.53 ± 0.03 for C1Bη).
In contrast with the results shown above in RBL-2H3 cells for C1Bε
and C1Bη, no translocation was observed for C1Bδ and C1Bθ when the
same concentrations of DOcPA were used (Fig. 5E and Table 5) and
some degree of translocation was only observed for these domains
when high concentrations of DOcG were used (e.g. 12 μg/ml) (Fig. 5F
and Table 5). In this case the Rmax was 0.43 ± 0.01 for C1Bδ (but
note that membrane localization was observed in 53% of the cells) and
0.37 ± 0.03 for C1Bθ (membrane localization in 48% of the cells). No
membrane translocation was observed for these two domains when
20 μg/ml of DOcPA and 4 μg/ml of DOcG were added together
(Table 5). However, when the addition was 20 μg/ml of DOcPA plus
12 μg/ml of DOcG, i.e. high concentrations of both activators, some
translocation was observed with Rmax being 0.44 ± 0.01 for C1Bδ and
0.47 ± 0.01 for C1Bθ (Table 5 and Fig. 5G).
These results conﬁrm that C1Bδ and C1Bθ need higher concentra-
tions of activators for their membrane translocation. Furthermore,
C1Bε and C1Bη may respond to DOcPA without the need for DOcG
and that a combination of low concentrations of both activators triggers
a bigger membrane translocation of these two domains. In contrast, in
the case of C1Bδ and C1Bθ they do not respond to DOcPA and high
combined concentrations of DOcG (12 μg/ml) and DOcPA (20 μg/ml)
are required for their membrane translocations.
4. Discussion
Structural studies have established that all C1 domains have a similar
fold [27–33] based on a compact α/β structural unit, which tightly binds
two zinc ions. This fold contains an unzipped β-sheet that forms a single
ligand-binding site for diacylglycerol or phorbol esters (Thr12, Gly23
and Leu21) in its top, surrounded by hydrophobic residues that are
involved in membrane insertion [29].
Conventional and novel PKCs contain two C1 domains, C1A and C1B,
although the exact function of each of these domains and the reason for
the existence of this double domain are not fully clear. Much research
effort has focused on trying to understand the speciﬁc function of
these domains, which we have reviewed in detail elsewhere [2].
Studying C1A domains is hampered by the difﬁculty involved in
obtaining them in soluble form from transfected cell cultures. C1B,
however, can be obtained in soluble form and in sufﬁcient amounts to
carry out studies like the one reported here, whose objective was to
compare the membrane binding afﬁnity of the C1B domains of the four
novel PKCs, studying themside by side and using bothmodelmembranes
and live cells.
As regard the C1B domain, we compared the sequence homology of
the four domains from novel PKCs, using the program ClustalW2
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) and the sequences for
the C1B domains deduced from Uniprot (http://www.uniprot.org/) for
PKCε (code P16054), PKCη (code P23298), PKCδ (code P28867) and
PKCθ (Q02111), all of them from mouse. It was seen that whereas ε
and η have 84% homology between them, both of them only have 62%
homology with δ and 66% with θ. On the other hand, δ and θ present
80% homology.
In the ﬁrst part we studied the binding of the C1B domains to
membranes using a FRET assay. From the binding afﬁnity results (the
reciprocal of the apparent KD values) for the four domains, it can be
concluded that C1Bε and C1Bη have a much higher binding afﬁnity
than C1Bδ and C1Bθ. This pattern of two well differentiated groups
with respect to C1B domains from novel PKCswas conﬁrmed by studies
both in the presence and absence of diacylglycerol, when all of them
showed similar membrane afﬁnity in the presence of saturating PMAls were transfected with ECFP-C1Bδ, ECFP-C1Bθ, ECFP-C1Bε and ECFP-C1Bη contructs, as
ated amounts of soluble diacylglycerol (DOcG) and/or soluble phosphatidic acid (DOcPA).
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Table 5
Plasmamembrane translocation parameters in RBL-2H3 cells stimulatedwith DOcPA and/
or DOcG.
Stimulation N cells M.L., % Rmax t½, s
C1Bε-ECFP
20 μg/ml DOcPA 22 96 0.44 ± 0.02 3 ± 1
15 μg/ml DOcPA 31 83 0.40 ± 0.02 3 ± 1
10 μg/ml DOcPA 24 79 0.33 ± 0.03 3 ± 1
5 μg/ml DOcPA 28 46 0.25 ± 0.03 6 ± 1
2 μg/ml DOcPA 0
12 μg/ml DOcG 29 93 0.46 ± 0.02 3 ± 1
8 μg/ml DOcG 23 78 0.39 ± 0.01 3 ± 1
4 μg/ml DOcG 46 34 0.29 ± 0.03 4 ± 1
2 μg/ml DOcG
10 μg/ml DOcPA + 4 μg/ml DOcG 21 95 0.51 ± 0.01 3 ± 1
5 μg/ml DOcPA + 4 μg/ml DOcG 18 94 0.41 ± 0.03 3 ± 1
2 μg/ml DOcPA + 2 μg/ml DOcG 0
C1Bη-ECFP
20 μg/ml DOcPA 24 96 0.41 ± 0.02 3 ± 1
15 μg/ml DOcPA 22 90 0.37 ± 0.01 3 ± 1
10 μg/ml DOcPA 22 59 0.21 ± 0.02 3 ± 1
5 μg/ml DOcPA 0
12 μg/ml DOcG 27 92 0.41 ± 0.01 4 ± 1
8 μg/ml DOcG 22 36 0.43 ± 0.01 3 ± 1
4 μg/ml DOcG 31 19 0.26 ± 0.01 6 ± 1
2 μg/ml DOcG 0
10 μg/ml DOcPA + 4 μg/ml DOcG 27 100 0.53 ± 0.03 2 ± 1
5 μg/ml DOcPA + 4 μg/ml DOcG 31 45 0.34 ± 0.01 3 ± 1
2 μg/ml DOcPA + 2 μg/ml DOcG 0
C1Bδ-ECFP
50 μg/ml DOcPA 0
30 μg/ml DOcPA 0
20 μg/ml DOcPA 0
12 μg/ml DOcG 21 53 0.43 ± 0.01 8 ± 1
8 μg/ml DOcG 25 44 0.28 ± 0.02 11 ± 3
4 μg/ml DOcG 0
20 μg/ml DOcPA + 4 μg/ml DOcG 0
20 μg/ml DOcPA + 12 μg/ml DOcG 32 81 0.44 ± 0.01 8 ± 1
C1Bθ-ECFP
50 μg/ml DOcPA 0
30 μg/ml DOcPA 0
20 μg/ml DOcPA 0
12 μg/ml DOcG 21 48 0.37 ± 0.03 3 ± 1
8 μg/ml DOcG 21 28 0.29 ± 0.02 4 ± 1
4 μg/ml DOcG 0
20 μg/ml DOcPA + 4 μg/ml DOcG 0
20 μg/ml DOcPA + 12 μg/ml DOcG 41 75 0.47 ± 0.01 5 ± 1
M.L. is membrane localization and indicates the percentage of cells responding to DOcPA
and/or DOcG stimulation with plasma membrane translocation. Rmax is the maximal
relative increase in plasma membrane localization of the domain. t1/2 is the half time of
translocation.
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clearly distinguished when the experiments were conducted using
living cells and stimulating membrane binding with either an antigen
or permable forms of phosphatidic acid and/or diacylglycerol. Note
that this division of novel C1B domains into two groups correlates
well with the sequence homology mentioned above.
Several observations deserve comment. One is related with the
speciﬁcity for the different anionic phospholipids studied. C1Bε, C1Bη
and C1Bθwere seen to have a higher speciﬁcity for POPA, judging from
the KD values. Only C1Bδ had a higher speciﬁcity for POPS. If the concen-
tration of anionic phospholipids in the membrane was increased from 5
to 40 mol%, the membrane binding afﬁnity increased by up to one
order of magnitude, illustrating the importance of anionic phospholipids
for enabling the binding of C1B domains to the membrane. This was also
shown by the experiments in which DOG was omitted from the model
membranes, especially in the case of C1Bε and C1Bη in the presence of
POPA, when the effect of DOG was very modest (in the case of C1Bη the
KD fell from 1.82± 0.50 μM in the absence to 1.11± 0.03 in the presence
of 5 mol% DOG). However, in the presence of PMA at 1 mol%, which is a
very high concentration, the membrane binding differences between
domains and their speciﬁcity for phospholipids, were minimized.
It should be remarked that the inﬂuence of the interaction with
anionic phospholipids on the membrane binding of C1B domains of
novel PKCswas clearly demonstrated by the experiments in the absence
of DOG, since in this type of experiment it was very clear that C1Bε and
C1Bη had a much higher membrane binding afﬁnity than C1Bδ and
C1Bθ, as was the case for all the anionic phospholipids tested. It is to
be expected that this would also be the case in physiological conditions
for translocation to the cell plasmatic membrane. As regard diacylglyc-
erol, the physiological levels of this lipid in biomembranes were
reviewed in [34]. For example, quantitative measurements of diacyl-
glycerol present in stimulated cells have shown that it may reach
1.45 mol% of the total lipid concentration [35] or about 2 mol% [36].
Higher levels have been described in other systems, e.g. the 10 mol%
observed in transformed 3T3 cells [37] while in other membranes the
levels may vary considerably. In addition to that, high levels may be
locally expected in points close to where the enzymes catalyze their
formation. So the concentrations of diacylglycerol used in this work
can be considered physiological andwell within the range of diacylglyc-
erol concentrations used in standard procedures for PKC activation
assays, which use values similar to those used here [38] or even as
high as 11.5 mol% with respect to total lipid [39] or 19 mol% [40] or
25 mol% [41]. With respect to the physiological concentration of
phosphatidylserine in the inner monolayer of eukaryotic plasma
membranes, such as in erythrocyte or platelet cells, this reaches roughly
20 mol% [42–44], so that the concentration used in this work is within
the physiological range.
It is also interesting that PKCη showed a higher membrane binding
afﬁnity than PKCε in the absence of DOG and when POPS and POPG
were the anionic phospholipids present. Nevertheless, POPA was the
anionic phospholipid forwhich the lowestKDwas observed. Phosphatidic
acid is produced inmembranes by enzymatic activity through two routes,
the action of phospholipaseD and that of diacylglycerol kinases. Phospha-
tidic acid constitutes approximately 1–5% of total cellular lipids [45,46]
and is found both in plasma and innermembranes like the Golgi network
[47–49]. Nevertheless, it should be taken into account that local concen-
trations will be considerably higher in the immediate vicinity of the
points where phosphatidic acid is being synthesized. It is interesting
that phosphatidic acid has been seen to be important in the activation
of PKCε [10] and, although it has been shown that this phospholipid
binds to the C2 domain of PKCε [10,11,50,51], the ﬁndings described
here suggest that lipid microdomains containing both PA and diacylglyc-
erol also play an important role in inducing the anchorage of C1 domain
in membranes.
The experiments carried out with RBL-2H3 cells conﬁrmed that two
groups can be deﬁned within the C1Bs domains of novel PKCs. Thiswas observed when cells were stimulated with DNP-HSA, although dif-
ferenceswere found in the time of translocation rather than in themax-
imum translocation rate. It seems that high concentrations of activators
are generated when using this concentration of antigen and thus this
experiment has a similarity with the one in which we used PMA
(Table 3).
When using permeable activators, it was found that whereas high
percentages of C1Bη and C1Bε may be translocated to the cell mem-
brane following the addition of phosphatidic acid, C1Bδ and C1Bθ need
the addition of diacylglycerol before their translocation. According to
our observations made in model membranes, if enough phosphatidic
acid can be incorporated in the cell membranes the four domains will
be translocated, but when soluble phosphatidic acid is added only a
limited concentration is expected to be reached in the cell membrane,
which will not be sufﬁcient for the translocation of C1Bδ and C1Bθ in
the absence of diacylglycerol. It was described that direct phosphatidic
acid stimulation produces a similar pattern of plasma membrane
translocation to that produced by antigen stimulation in RBL-2H3 cells
[10]. Previous in vitro experiments in our laboratory demonstrated the
preference of the isolated C2 domain of PKC to preferentially bind
Fig. 6. Alignment of the amino acid sequences of the C1B domains of novel PKCs. The highlighted residues correspond to those positively charged residues (K and R) that are different
between the couple C1Bδ–C1Bθ and the couple C1Bε–C1Bη. Residue R286 of C1Bη is underlined because is close to I285 that occupies a position analog to R282 in C1Bε, this is being
one of the apparently signiﬁcant differences with respect to couple C1Bδ–C1Bθ. The molecular model shown corresponds to C1Bε, modeled on the basis of C1Bδ (1PTR) as described in
the text. Zn2+ cations are shown as blue spheres and phorbol ester in orange.
1907A.L. Egea-Jiménez et al. / Biochimica et Biophysica Acta 1838 (2014) 1898–1909phospholipid vesicles containing phosphatidic acid [52,53]. The results
obtained previously also suggest that the full-length enzyme needs a
continuous source of PtdOH to translocate to the plasma membrane in
physiological conditions [10].We have also used in this paper exogenous
PtdOH (DiC8-PtdOH) because it can be added to the cell culture medium
and is incorporated rapidly into cell membranes where it subsequently
participates in cellular functions [54].
It is known that diacylglycerol may be formed from phosphatidic
acid by the action of phosphatases in cells. Therefore it may be
suspected that the exogeneous PA that is added in some experiments
reported above may be transformed in DAG, but available experimental
evidence indicates that the formation of both DAG and PA upon cell
stimulation occurs with t1/2 of several minutes [55,56]. However we
observed that the translocation to membrane of C1 domains induced
by exogeneous PA has t1/2 of a few seconds. Furthermore, it is reported
above (Fig. 5) that C1Bδ and C1Bθwere not translocated to membranes
even after 10 min of the addition of 50 mg /ml of soluble phosphatidic
acid, strongly indicating that the effect is really due to phosphatidic
acid and not to the formation of diacylglycerol by hydrolysis of this
exogeneously added phospholipid.
We have observed that C1Bε and C1Bη are translocatedmore rapidly
to the membrane than C1Bδ and C1Bθ and hence this may be due to
both activators acting together. However C1Bδ and C1Bθ need a longer
timer and this may be due to the fact that they require a higher concen-
tration of both activating lipids. In order to identify the role played by
each of these activating lipids we used soluble forms added exogenous-
ly. The results showed that the addition of soluble PA only triggered the
translocation of C1Bε and C1Bη in a very rapid way (in a seconds time
scale) whereas the translocation of C1Bδ and C1Bθwere not triggered.
It would be interesting to ascertain whether if the differences
observed between the C1Bs of novel PKCs are related with their physio-
logical specializations. It has been described, for example, that the
activation of PKCε and PKCδ has opposing consequences in ischemic
myocardium [57].Whereas PKCε activation has a cardioprotective effect
[58], PKCδ activation mediates much of the acute injury induced after
transient myocardial ischemia [59,60]; also PKCθ and PKCη play
different roles in signal transductions in T cells.When an immunological
synapse is formed between a T cell and an antigen-presenting cell, PKCθ
concentrated in the central region of the synapse, while PKCη diffuses
over the whole area of the synapse, suggesting that each may bind to
a different activator in the membrane [61]. In addition, the deﬁciency
of PKCη or PKCθ in T cells had opposing effects in knockout mice,
since PKCη knockout had a higher CD4 to CD8 ratio [61]. Given thesedifferences in functions and effects within the same cells, it seems
plausible that PKCε and PKCηmay have different degrees of sensitivity
to activators from PKCδ and PKCθ (as we have shown in this paper):
each of these isoenzymes would be translocated to the area of the
plasma membrane or to the organelle where there is a more favorable
combination of diacylglycerol and anionic phospholipid, even though
some of them may be more responsive to low concentrations of one of
these activators.
It is widely known that the C1 domain binds to the membrane by
interacting with DAGs (or phorbol esters). It has been observed that
each C1 domainmay have preference for a certain subcellular membrane
and these differences help to explain the divergent localization and
distinct functional roles of the full-length proteins, which contains
them. This selectivity has been explained by their capacity to discriminate
between DAG pools [62]. But here wemay demonstrate that electrostatic
interactions provided by anionic phospholipids also make an important
contribution to the speciﬁc targeting of C1 domains to cell membranes.
These protein–phospholipid interactions have been found to be quite
important for the binding ofmany extrinsic proteins, such as cytochrome
c [63,64], myelin basic protein [65], phospholipases [66], K-Ras [67],
charybdotoxin [68], cardiotoxin [69] and Aβ peptides [70].
It should be mentioned that diacylglycerols bearing short fatty acyl
chains show a very high activation capacity with respect to PKC [38].
Both phosphatidic acid [71] and diacylglycerol [34], are lipids that may
induce negative curvature and this may favor protein insertion in the
membrane but this effect will be the same for all the isoenzymes and
therefore will not affect the conclusions obtained about the different
behavior of the isoenzymes with respect to membrane binding.
In order to examine the possible structural basis for the observed
differences between the two couples of C1B domains of novel PKCs we
have elaborated an alignment of their sequences as shown in Fig. 6.
We highlight these positively charged residues that are not conserved
when comparing both couples of domains and that are present in
C1Bε and C1Bη, such as K274, K277 and R282 (C1Bε) and K277 and
K280 (C1Bη). In the case of C1Bη, the residue aligned with R282 in
C1Be is however I285 but it might be that the following residue
(R286) may compensate for that. Site-targeting mutations should be
carried out to conﬁrm these suggestions.
Fig. 6 also shows a molecular modeling of C1Bε, although a high
resolution structure for this domain is not known. To overcome this
we have carried out a modeling by using C1Bδ as a basis (PDB 1PTR)
and using Geno3D website (Pôle Bioinformatique Lyonnais Geno3D,
http://pbil.ibcp.fr/htm/index.php). The model includes a molecule of
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Since the phorbol ester molecule must be embedded in the membrane,
the residues highlighted in the alignment shown in themodel are most
probably located at the membrane lipid–water interface and this is
compatible with their possible interaction with the negatively charge
phospholipids of the membrane.
Taken together, our results show that (i) C1B domains from novel
PKCs have different binding afﬁnities for model membranes depending
on the presence or not of diacylglycerol and of speciﬁc anionic phospho-
lipids, (ii) this is also observed in RBL-2H3 cells in which the different
C1B domains were expressed (iii) two groups of C1B domains from
novel PKCs can be established as a function of their membrane binding
afﬁnity: those from PKCε and PKCη with a higher membrane binding
afﬁnity and those with PKCδ and PKCθwith a low afﬁnity.
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